Rockwell Medical Inc.

Industry

  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals
  • Digital Health
    • Disease Management
  • Biotechnology

Other Names/Subsidiaries

  • Aspreva Pharmaceuticals
  • BMC Holding
  • Equazen Nutraceuticals
  • Laboratorien Hausmann
  • Médipole Distribution
  • Minerva
  • OM PHARMA
  • Pharma-Singer
  • Potter’s (Herbal Supplies)
  • Renapharma
  • Sun Store
  • Vifor
  • Vifor Uriach Pharma
See more in Biomedtracker

Latest on Rockwell Medical Inc.

Scrip

Asia Deal Watch: BeiGene Gets Chinese Rights To Two EUSA Rare Disease Therapies

 
• By Ian Haydock, Vibha Ravi, Jung Won Shin, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . EUSA, BeiGene Ink $160m Alli

Pink Sheet

Keeping Track: A Busy Week For Regenerative Medicine, A Surprise Priority Review For Vascepa, And Tazemetostat Aims For Accelerated Approval

 
• By Michael Cipriano, Bridget Silverman, and Brenda Sandburg

The long Memorial Day weekend didn't slow down the US Food and Drug Administration and industry, which produced a burst of drug development news in the closing days of May. Here's your news in brief:

Pink Sheet

Keeping Track: Oncology Submissions From Blueprint, Y-mAbs, BMS/bluebird; Approvals For BMS’ Reblozyl, LFB’s SevenFact

 
• By Bridget Silverman

Oncology products took center stage last week, thanks to submissions for Blueprint Medicines Corp. ’s targeted therapy pralsetinib, Y-mAbs’ antibody therapeutic naxitamab, bluebird bio Inc. and Br

Scrip

Finance Watch: Rough US Stock Market Doesn't Stop Biopharma IPOs As Six More Go Public

 
• By Mandy Jackson

Eight biopharmaceutical firms have gone public in October, despite a sharp decline in stock values with the Nasdaq Biotechnology Index (NBI) falling 14.6% in the past month. Orchard Therapeutics Ltd.